BIOCORP: Novo Nordisk (NVO) Gears Up to Acquire BIOCORP for 154M Euros
Novo Nordisk (NVO) enters into negotiations to acquire a majority stake in BIOCORP, followed by a tender offer to acquire all remaining shares in BIOCORP for a total equity value of 154 million Euros.
Read full article »
BIOCORP is a France-based company that develops and commercializes medical devices and smart drug delivery systems for the healthcare industry.
Read more